Trouble reading this e-mail? View it in your browser.

10 March 2016
Header image


Country Reports in the European Semester 2016
07 March 2016

EFPIA welcomes the publication by the European Commission of the Country Reports as part of the European Semester 2016. The reports highlight, among other things, issues relating [...] Read more

From our blog

From our blog

IMI’s Co-operative Approach to Research is a Game Changer for Global Health (Guest Blog)
10 March 2016 by Paul Stoffels

For decades, pharmaceutical companies operated in silos, guarding their secrets from one another with the aim of producing an effective and rewarding therapy.

The effects of working together are changing that – easing the burden of research and leading to better healthcare solutions, faster.

Read more



Pharmaceuticals and the Environment: Interview with Bengt Mattson

Bengt Mattson, Co-Chair, Pharmaceuticals in the Environment Joint-Industry Task Force, explains how the pharmaceutical industry is addressing the potential environmental impacts of a pharmaceutical. 

To learn more about the medsdisposal campaign and how medicines disposal is arranged in your country, you can access

For more information about pharmaceuticals in the environment, please click here.

View video

Events calendar

Events Calendar

EFPIA Annual Conference 2016
On 15/06/2016 (Radisson Hotel, Brussels)

This year's EFPIA Annual Conference will take place on 15 June 2016, at the Radisson Hotel in Brussels. The event will examine the challenges faced by healthcare systems in Europe, the exciting science that will play a key role in meeting these challenges and the long-term sustainability of healthcare delivery. An interactive exhibition will be set up to provide attendees with further insight into EFPIA’s current initiatives, which aim at facilitating a pan-European dialogue on the importance of shifting towards a model of outcomes-driven healthcare.
The final programme can be accessed here
Read more

Events Calendar

DIA 28th Annual EuroMeeting 2016
From 06/04/2016 to 08/04/2016 (Hamburg, Germany)

In a world in which new therapies are being developed at a phenomenal rate, is innovation always the answer?

The DIA EuroMeeting is the premier platform on which to exchange ideas with thought leaders on key challenges and opportunities facing health care product development professionals. 

By attending EuroMeeting 2016, you will discuss issues while building relationships with your regulatory, industry and academia counterparts who are guiding the trends.


Read more

Events Calendar

2016 China/EU Pharmaceutical Industry Forum
On 05/04/2016 (Hamburg, Germany)

CPIA and EFPIA will organise a workshop on 5 April 2016, in Hamburg, Germany, with the following areas of focus: an overview of the pharmaceutical market in China/EU; Pharmaceuticals in the Environment; the Drug Administration Law (DAL) revision; and the implementation of new EU legislation. 

The workshop takes place the day before the start of the DIA Euro meeting, which will facilitate for those who already plan to attend the DIA Euro meeting in Hamburg.
This will be an excellent opportunity to listen to e.g. a presentation on the revision of the Drug Administration Law in China and the European Commission strategy for Pharmaceuticals in the Environment (PIE) and also get direct information from the Commission on what will happen in 2019 re Identification and authentication of medicines in Europe as a result of the implementation of the Falsified Medicines Directive.
Please see the programmme for further details. Below, you can access the speakers' presentations:
European Commission strategy for Pharmaceuticals in the Environment (PIE), Patrizia Tosetti, Medical products: quality, safety, innovation, European Commission
Read more

Events Calendar

EFGCP Multi-Stakeholder Workshop & Discussion on How to Ensure Optimal Ethical Review within the New Clinical Trials Regulation? Where do we currently stand with the implementation in different Member States
On 13/04/2016 (Brussels)

Organised by EFGCP with the partnership of EORTC

A revision of the Clinical Trials Regulation was adopted by European legislation makers in 2014. This revised legal framework will bring significant advances compared with today’s situation and is expected to be fully implemented as soon as the supporting Clinical Trials Portal and Database are fully functional (2H2017).

For more information about the programme, please click here.

Read more

Events Calendar

Biovision World Life Science Forum
From 13/04/2016 to 14/04/2016 (Lyon, France)

The Biovision World Life Science Forum is fostering a unique approach to meet and connect with, as well as collaborate between international decision-makers from the academic, civil society, policy-making and private sectors, whether industrial or investors.

Biovision 2016's pattern is dedicated to strengthening Action & Interaction for Innovation with:

  • A prospective part with a main theme on "Global health and Prevention" and specific paths (Medicine & Humanities, Vaccines, Cancer Prevention and Digitalised Patients) with workshops, plenary sessions and calls for action.
  • Catalyser & Investor parts with reinforced and segmented sourcing allowing more specific expertise for the evaluation and follow up of the projects, including financing.
Read more

What we are reading

What we are reading

Reforms needed to ensure sustainable healthcare system
10 March 2016 (New Europe)

The President of Hellenic Association of Pharmaceutical Companies (SFEE), Pascal Apostolides, spoke to New Europe about the challenges of the Greek pharmaceutical sector, noting the commitment of the industry to support the system with adequate supply of medicines and calling for a National Strategic Plan for a primary care reform to ensure and secure the right of patients for access to a modern and sustainable health system.

Read more

What we are reading

Launch of PRIME – Paving the way for promising medicines for patients
10 March 2016 (EMA)

The European Medicines Agency (EMA) launches today its new PRIME (PRIority MEdicines) scheme to strengthen support to medicines that target an unmet medical need. The scheme focuses on medicines that may offer a major therapeutic advantage over existing treatments, or benefit patients with no treatment options. These medicines are considered priority medicines within the European Union (EU).

Read more

What we are reading

COMBACTE Magazine: Combatting Bacterial Resistance in Europe
10 March 2016 (COMBACTE)

In Europe alone, 25,000 people die each year from resistant bacterial infections. Although most deaths occur in European regions with outdated care facilities, multi-resistant bacteria threaten even the most advanced of hospitals. Now, new strains are proving immune – to our current arsenal, at least.

Attempts to do the obvious – develop new antibiotics – have been fraught with challenges. Firstly, bacteria are very good at defending themselves from antibiotics, and devising ways of getting round these bacterial defenses is scientifically difficult. Secondly, regulatory requirements make running clinical trials of new antibiotics far from trivial. Finally, as new antibiotics are used sparingly, there is a lack of incentives for industry to develop them. The truth is, no institution, company or even country can solve these problems alone. 

The Innovative Medicines Initiative program New Drugs for Bad Bugs (ND4BB), of which COMBACTE forms a key part, is addressing these issues. Through ND4BB, the best and brightest of the pharmaceutical industry and medical science are pooling their knowledge and sharing data, findings and insights with each other. We are building an extensive network to span the continent. And there is interest elsewhere, too. By creating the perfect environment to develop new medicines we may eventually see new antibiotics get to the patients that need them. The foundation has now been laid. And it’s a game-changer. 

Read more

About EFPIA updates
Unsubscribe to be removed from this mailing list | Update your subscription

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 34 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.
Leopold Plaza Building
Rue du Trône 108
B-1050 Brussels (Belgium)
Tel: +32 (0)2 626 25 55
Follow EFPIA
Twitter LinkedIn Youtube Google + Pinterest E-mail